Quinazoline derivatives as angiogenesis inhibitors

Details for Australian Patent Application No. 2004263360 (hide)

Owner AstraZeneca AB

Inventors Hennequin, Laurent Francois Andre

Agent Davies Collison Cave

Pub. Number AU-A-2004263360

PCT Pub. Number WO2005/014582

Priority 0318422.3 06.08.03 GB

Filing date 5 August 2004

Wipo publication date 17 February 2005

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

23 February 2006 PCT application entered the National Phase

  PCT publication WO2005/014582 Priority application(s): WO2005/014582

2 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263361-Method and apparatus for producing an article for displaying an image

2004263355-Method of peptide synthesis